Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection
Status:
Unknown status
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This study will be conducted on 30 patients with mucocutaneous complaints and documented HCV
infection. The study will be done at Tropical medicine department , Tanta university. It will
be conducted between June2014 and November 2014.
The aim of the study is to assess efficacy of Ribavirin in the management of mucocutaneous
extrahepatic manifestations of HCV infection.